As of March 1, 2026, the National Pharmacare Plan (Plan NP) provides 100% coverage of select diabetes medications, menopausal hormone therapy (MHT), and contraceptives for any B.C. resident enrolled in MSP. The federal government contributes funding for national pharmacare.
With the launch of Plan NP, the pricing of insulin as a PharmaCare benefit is regulated under the Drug Price Regulation and subject to the Maximum Pricing Policy, and subject to the Full Payment Policythrough an amendment to the Provider Regulation.
Some benefits are partially covered, subject to Low Cost Alternative (LCA) pricing. The public is being encouraged to ask their pharmacist or prescriber to adapt to or prescribe fully covered benefits.
Expanded coverage for certain diabetes-related devices and supplies will begin on April 1, 2026. Details will be available soon in the PharmaCare Newsletter.
Plan NP dispenses do not count towards the Fair PharmaCare deductible or family maximum.
As someone managing diabetes in British Columbia, I truly appreciate the launch of the National Pharmacare Plan (Plan NP) taking effect from March 1, 2026. The fact that insulin and other essential diabetes medications like Empagliflozin, Metformin combinations, and Saxagliptin will be fully covered removes a huge financial burden. Insulin affordability has long been a challenge, and being regulated under the Drug Price Regulation and Maximum Pricing Policy provides security against price gouging. The additional coverage for menopausal hormone therapy and contraceptives is equally beneficial for many residents, ensuring access to critical treatments without out-of-pocket costs. I also find it noteworthy that expanded coverage for diabetes-related devices and supplies will start from April 1, 2026. This means better access to important tools like glucose monitors, which are key for daily diabetes management. Another great aspect is that dispenses under Plan NP won’t count towards the Fair PharmaCare deductible or family maximum, easing cumulative cost pressures many families face. However, I have personally learned the importance of talking to pharmacists or doctors about prescribing fully covered medication benefits subject to the Low Cost Alternative pricing. It’s encouraging to see that public health authorities motivate patients to opt for these fully covered options, making healthcare more affordable overall. Local resources such as the BC Diabetes Foundation and community support groups provide excellent guidance and education, which complement this pharmacare program very well. This coordinated effort between federal funding, provincial administration, and community outreach offers an optimistic outlook for people living with diabetes or other related conditions in B.C. It’s truly a step forward toward accessible, affordable medication for all eligible residents.
